Open Access. Powered by Scholars. Published by Universities.®

Arts and Humanities Commons

Open Access. Powered by Scholars. Published by Universities.®

History of Science, Technology, and Medicine

1999

Cetuximab

Articles 1 - 3 of 3

Full-Text Articles in Arts and Humanities

Oncolog, Volume 44, Number 12, December 1999, Margaret E. Goode, Dawn Chalaire, John Mendelsohn Md Dec 1999

Oncolog, Volume 44, Number 12, December 1999, Margaret E. Goode, Dawn Chalaire, John Mendelsohn Md

OncoLog MD Anderson's Report to Physicians (All issues)

  • Collaboration Between Scientists, Clinicians Moves Apoptosis Studies Forward
  • Answering the Who, What, and How of Medical Physics
  • USHERING IN NEW TECHNOLOGIES: Medical Physicists Focus on IMRT, Ultrasound-Guided Brachytherapy
  • DiaLog: Building Better Patient Care on the Foundation of Scientific Research, by John Mendelsohn, MD, President, Professor of Clinical Investigation
  • House Call: Make Cancer Prevention Part of Your New Year's Resolutions


Oncolog, Volume 44, Number 04, April 1999, Dawn Chalaire Apr 1999

Oncolog, Volume 44, Number 04, April 1999, Dawn Chalaire

OncoLog MD Anderson's Report to Physicians (All issues)

  • Pancreatic Tumor Team Studies Disease Mechanisms, Reverses Conventional Approach
  • Patient Helps Underwrite Familial Cancer Study
  • Stomach Cancer Protocols Offer Options
  • Gastric Cancer's Low Survival Rate and High Relapse Rate Challenge Physicians
  • House Call: Environmental Carcinogens: Fact and Fiction
  • Protocols: Pancreatic Cancer Protocol Options Include Gemdtabine and Marimastat


Oncolog, Volume 44, Number 03, March 1999, Dawn Chalaire, Beth W. Allen, Alison Rufffin Mar 1999

Oncolog, Volume 44, Number 03, March 1999, Dawn Chalaire, Beth W. Allen, Alison Rufffin

OncoLog MD Anderson's Report to Physicians (All issues)

  • Vaccines, Other New Options Expand Renal Cancer Therapy Program
  • Thirteen-story Alkek Hospital Makes Debut
  • Training Takes Prevention and Early Detection Worldwide
  • Nephrectomy Before or After Systemic Therapy­--That Is the Question
  • House Call: Alcohol and Cancer: Making Sense of a Cocktail of Risks and Benefits
  • Protocols: Renal Cell Carcinoma Trials Offer Therapies for Treated and Untreated Patients
  • Compass: New Quarterly Supplement Offers Perspectives on Clinical Guidelines